Soft Tissue Sarcoma — Trials

Soft Tissue Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

1,383 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 338
Recruiting: 188
Ph III recruiting: 14
Growth YoY: −16.5%
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (197)

clinicaltrialsPublishedShowing 1,001–1,050 of 1,383 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03798795	Radiomics for Tumor Grading of Soft Tissue Sarcomas.	completed	—	285	Technical University of MunichOTHER	1	Apr 10, 2019	clinicaltrials
NCT02565758	ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors	completed	Phase 1	85	AbbVieINDUSTRY	3	Apr 5, 2019	clinicaltrials
NCT03904368